SAMDaily.us | MOD | 66 | Explore 3072 Reagent Kit

SAMDAILY.US - ISSUE OF JULY 22, 2022 SAM #7539
MODIFICATION

66 -- Explore 3072 Reagent Kit

Notice Date: 7/20/2022 4:54:28 PM
Notice Type: Combined Synopsis/Solicitation
NAICS: 325413 — In-Vitro Diagnostic Substance Manufacturing
Contracting Office: NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
ZIP Code: 20892
Solicitation Number: 75N95022Q00325
Response Due: 7/27/2022 7:00:00 AM
Archive Date: 08/11/2022
Point of Contact: fred Ettehadieh
E-Mail Address: fred.ettehadieh@nih.gov
(fred.ettehadieh@nih.gov)
Description: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii)�� The solicitation number is 75N95022Q00325 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13�Simplified Acquisition Procedures; and FAR Part 12�Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. (iii)�� The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2022-06, with effective date May 26, 2022. (iv)�� The associated NAICS code 325413 - In-Vitro Diagnostic Substance Manufacturing and the small business size standard is 1,250 employees.� This requirement is Full and Open competition with no set-aside restrictions. This is a Brand Name or Equal requirement for Olink Explore 3072 Reagent Kit. (v)�� This requirement is for the following items: The National Institute on Aging (NIA) requires performing triple quadrupole mass spectrometry with the MxP Quant kit, up to 3072 proteins plasma and CSF. This analysis is vital to the NIA proteomics research. One Explore 3072 Kit includes: Olink� explore 384 probe kit (Inflammation � Quantity: 5 Olink� explore 384 probe kit Inflammation II � Quantity: 5 Olink� explore 384 probe kit Oncology � Quantity: 5 Olink� explore 384 probe kit Oncology II � Quantity: 5 Olink� explore 384 probe kit Cardiometabolic � Quantity: 5 Olink� explore 384 probe kit Cardiometabolic � Quantity: 5 Olink� explore 384 probe kit Neurology � Quantity: 5 Olink� explore 384 probe kit Neurology II � Quantity: 5 Olink� Explore Sample prep 1.0 � Quantity: 10 Olink� Explore Sample prep 2 � Quantity: 10 Olink� Explore plate control � Quantity: 10 Olink� Explore Target 96/Explore Sample Diluent � Quantity: 10 (vi)�� Salient characteristics are as follows: Eight Olink� Explore 384 Probe kits (Inflammation, Inflammation II, Oncology, Oncology II, Cardiometabolic, Cardiometabolic II, Neurology, Neurology II) � reagents and control The kits come complete with all the reagents, will allow for the targeted proteomic profiles of plasma and CSF samples using Mosquito, the Dragonfly and the Epmotion in the lab.� This kit will help us perform targeted proteomic identification and quantitation in human plasma.� Eight (8) Olink� explore 384 probe kit (Inflammation, Inflammation II, Oncology, Oncology II, Cardiometabolic, Cardiometabolic II, Neurology, Neurology II), and two each of sample prep 1 (2), sample prep 2 (2), plate controls (2) and sample diluent (2). (vii)�� The Government anticipates award of a firm fixed-price purchase order for this acquisition. The anticipated delivery date is within 90 days after receipt of order (ARO). Delivery will be f.o.b. destination. The place of delivery and acceptance will be 251 Bayview Boulevard, Baltimore, Maryland, 21224. (viii)�� The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses:� https://www.acquisition.gov/browse/index/far ��https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html �� (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.211-6, Brand Name or Equal (Aug 1999) FAR 52.212-1, Instructions to Offerors-Commercial Items (Nov 2021) FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021) FAR 52.225-4 Alternate III, Buy American-Free Trade Agreements-Israel Trade Act Certificate (Feb 2021) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far ��https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html � (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text.� Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Items (May 2022) The following are also attached, however only one will be incorporated in the final award: NIH Invoicing Instructions with IPP NIH Invoicing Instructions without IPP (ix)�� The provision at FAR clause 52.212-2, Evaluation � Commercial Items (Nov 2021), applies to this acquisition. (a) The Government will evaluate quotations or offers in accordance with FAR 13.106-2 and award a purchase order from this solicitation to the responsible offeror whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotes: a. Technical capability of the item offered to meet the Government requirement; b. Price; c. Past performance [see FAR 13.106-2(b)(3)]. Technical and past performance, when combined, are significantly more important than price. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer�s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x)�� The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (xi)�� The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2021), applies to this acquisition. Addendum to this FAR clause applies to this acquisition and is attached. (xii)�� There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xiii)�� The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xiv)�� Responses to this solicitation must include sufficient information to establish the interested parties� bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. Respondents proposing on an equal product of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations from responsible sources must be submitted electronically (by email) to Fred Ettehadieh, Contracting Officer, at fred.ettehadieh@nih.gov by the closing date and time of this solicitation, and reference Solicitation number 75N95022Q00325. �Fax responses will not be accepted.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/01167d293c95450cbb6f6644ca98636f/view)
Place of Performance: Address: Baltimore, MD 21224, USA; Zip Code: 21224; Country: USA
Record: SN06395016-F 20220722/220720230111 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |

Loren Data's SAM Daily™

66 -- Explore 3072 Reagent Kit